Earnings History Data for Beam Therapeutics Inc. (BEAM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Beam Therapeutics Inc.

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2023	PM		BEAM	Beam Therapeutics	1,845	-1.22	-1.37	0.00	Beam Therapeutics GAAP EPS of -$1.22 beats by $0.03, revenue of $17.19M misses by $6.7M [11/8/2023 6:46 AM]	22.91	-2.08 (-8.32%)	25.29	0.30 (1.20%)	16.95 - 54.30	1,667,162	1,730,000	1,279
Beam Therapeutics GAAP EPS of -$1.22 beats by $0.03, revenue of $17.19M misses by $6.7M [11/8/2023 6:46 AM]
10-05-2023	PM	6:30 AM ET (May 10)	BEAM	Beam Therapeutics	2,490	-1.33	-1.36	0.00	Beam Therapeutics GAAP EPS of -$1.33 in-line, revenue of $24.2M beats by $8.56M [5/10/2023 8:47 AM]	35.94	1.43 (4.14%)	34.97	0.46 (1.33%)	27.77 - 73.27	922,863	800,000	3,612
Beam Therapeutics GAAP EPS of -$1.33 in-line, revenue of $24.2M beats by $8.56M [5/10/2023 8:47 AM]
28-02-2023	PM		BEAM	Beam Therapeutics Inc.	2,880	-0.54	-1.32	-0.85	Beam Therapeutics GAAP EPS of -$0.54 beats by $0.81, revenue of $20.04M beats by $7.31M [2/28/2023 6:59 AM]	40.41	1.42 (3.64%)	39.60	0.61 (1.56%)	27.77 - 80.00	949,894	770,000	1,233
Beam Therapeutics GAAP EPS of -$0.54 beats by $0.81, revenue of $20.04M beats by $7.31M [2/28/2023 6:59 AM]
07-11-2022	PM	6:30 AM ET (Nov 7)	BEAM	Beam Therapeutics	3,096	-1.56	-1.30	0.00	Beam Therapeutics GAAP EPS of -$1.56 misses by $0.26, revenue of $15.79M beats by $8.64M [11/7/2022 6:50 AM]	37.90	-4.90 (-11.46%)	39.07	-3.73 (-8.71%)	27.77 - 100.06	1,662,465	850,000	9,578
Beam drops plans to submit IND for sickle cell disease candidate in 2022 [11/7/2022 8:02 AM] Beam Therapeutics GAAP EPS of -$1.56 misses by $0.26, revenue of $15.79M beats by $8.64M [11/7/2022 6:50 AM] Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results [Nov-07-22 06:30AM] Top Biotech Stocks for Q4 2022 [Nov-04-22 05:46PM]
09-05-2022	PM		BEAM	Beam Therapeutics	2,598	-1.01	-1.10	0.00	Beam Therapeutics GAAP EPS of -$1.01 misses by $0.12, revenue of $8.43M [5/9/2022 6:47 AM]	33.19	-2.49 (-6.98%)	34.26	-1.42 (-3.98%)	32.90 - 138.52	1,567,393	1,240,000	1,885
Beam Therapeutics GAAP EPS of -$1.01 misses by $0.12, revenue of $8.43M [5/9/2022 6:47 AM] Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results [May-09-22 06:30AM] Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Misses Revenue Estimates [May-09-22 08:25AM]
28-02-2022	PM	6:00 AM ET (Feb 28)	BEAM	Beam Therapeutics	4,794	-0.85	-1.02	0.00	Beam Therapeutics GAAP EPS of -$0.95, revenue of $51.07M [2/28/2022 6:51 AM]	77.66	2.91 (3.89%)	72.05	-2.70 (-3.61%)	56.34 - 138.52	626,442	830,000	8,251
Beam Therapeutics GAAP EPS of -$0.95, revenue of $51.07M [2/28/2022 6:51 AM] Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results [Feb-28-22 06:30AM] Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Tops Revenue Estimates [Feb-28-22 07:55AM]
08-11-2021	PM		BEAM	Beam Therapeutics	6,201	-0.42	-0.78	0.00	Beam Therapeutics EPS beats by $0.38, misses on revenue [11/8/2021 6:10 AM]	99.01	9.48 (10.59%)	94.16	4.63 (5.17%)	33.14 - 138.52	685,810	430,000	4,188
Beam Therapeutics EPS beats by $0.38, misses on revenue [11/8/2021 6:10 AM] Beam Therapeutics wins FDA nod to start sickle disease trial for gene editing candidate [11/8/2021 12:32 PM] Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results [Nov-08-21 06:00AM] Beam Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to its Board of Directors [Nov-08-21 06:00AM] Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Misses Revenue Estimates [Nov-08-21 07:15AM]
10-08-2021	PM	6:30 AM ET (Aug 10)	BEAM	Beam Therapeutics Inc.	6,783	-0.95	-0.58	0.00	Beam Therapeutics EPS misses by $0.60, misses on revenue [8/10/2021 6:42 AM]	104.28	-2.68 (-2.51%)	104.28	0.0 (0.00%)	21.24 - 138.52	738,092	660,000	179
Beam Therapeutics EPS misses by $0.60, misses on revenue [8/10/2021 6:42 AM] Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results [Aug-10-21 06:30AM] Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates [Aug-10-21 07:45AM]
11-05-2021	PM	6:30 AM ET (May 11)	BEAM	Beam Therapeutics Inc.	4,430	-3.35	-0.72	-1.03	Beam Therapeutics EPS misses by $2.61 [5/11/2021 6:38 AM]	66.23	2.11 (3.29%)	57.30	-6.82 (-10.64%)	16.80 - 126.90	2,239,994	790,000	26,187
Beam Therapeutics EPS misses by $2.61 [5/11/2021 6:38 AM] Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results [May-11-21 06:30AM] Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Lags Revenue Estimates [May-11-21 07:45AM] Beam Therapeutics Takes $155M In-Process R&D Expense Hit To Bottomline, But Receives Buy Rating From Redburn Partners [May-11-21 12:16PM] Rocket Pharma Stock Drops After FDA Institutes Clinical Hold On RP-A501 Danon Disease Trial [May-11-21 12:28PM]
15-03-2021	PM	After the close (Mar 15)	BEAM	Beam Therapeutics Inc.	5,487	-0.72	-0.70	0.00	Beam Therapeutics reports Q4 results [3/15/2021 6:46 AM]	94.92	-3.50 (-3.56%)	99.60	1.18 (1.20%)	13.00 - 126.90	668,682	1,358,265	1,221
Beam Therapeutics names drug development expert as medical chief [3/15/2021 7:07 AM] Beam Therapeutics reports Q4 results [3/15/2021 6:46 AM] Beam Therapeutics Announces Business and Pipeline Progress and Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-15-21 06:30AM] Beam Therapeutics Appoints Amy Simon, M.D., Chief Medical Officer [Mar-15-21 06:15AM]
10-11-2020	PM		BEAM	Beam Therapeutics Inc.	1,869	-0.69	-0.57	0.00	Beam Therapeutics EPS misses by $0.12 [11/10/2020 6:35 AM]	37.60	0.67 (1.81%)	0.0	0.0 (0.00%)	13.00 - 38.89	376,160	527,712	0

10-11-2020	PM		BEAM	Beam Therapeutics Inc.	2,040	-0.69	-0.57	0.00	Beam Therapeutics EPS misses by $0.12 [11/10/2020 6:35 AM]	34.39	-3.47 (-9.17%)	37.50	-0.36 (-0.95%)	13.00 - 41.19	1,099,141	550,920	1,176